CCW has acquired nickel and copper properties to add to its flagship Cobalt, ON property that has been delivering bonanza silver and cobalt intercepts. Bullish Engulfing candle and pickup in accumulation make for a nice chart setup. --- COQUITLAM, BC, Feb. 16, 2021 /CNW/ - Canada Silver Cobalt Works Inc. (TSXV: CCW) (OTC: CCWOF) (Frankfurt: 4T9B) (the "Company"...
Falling Wedge breakout looming. Bullish MACD cross is a technical buy signal. Fundamentally undervalued. $11M mkt cap, 30M float. Profitable. $900K quarterly revenues and $2M in cash. Steady growth.
$3.2M in sales this year already for this $14M mkt cap gem and they keep adding new contracts. Seriously undervalued and under the radar, IMO. Chart is prime for a move with bullish MACD cross signalling the start of new bullish trend.
Symmetrical Triangle breakout. Bullish MACD cross. Likely gap up tomorrow after major news today: Empower Partners with Rexall(R) To Launch Integrated Healthcare Centres Partnership Accelerates Empower's Strategy To Execute National Healthcare Centre Expansion By Bringing Accessible and Progressive Primary Care and Para-Medical Care to Millions of...
$13.2M mkt cap, 3.5M float. Freshly uplisted to NASDAQ. Closed $11M oversubscribed financing at $5.25 on January 14th and trading at discount at $4.40. Oversold on the daily (RSI @ 28). Accum/Dist is evening out after 3 days of selloff. Gap at 6.41. Cash + assets exceed current market cap.
Classic Inverse Head & Shoulders breakout on good volume. 4.16 about to get filled and likely $5+ coming before the week's end. Promo campaign is under way and news of sales and/or uplisting to TSX/NASDAQ is expected.
NPTH is significantly undervalued compared to peers: - $33M mkt cap with $50M revenue in 2019 - < 1 EV/sales vs 18.24x industry avg - Recent $12M financing at .90 - Insider options at .87 + open market buys - In major historical support zone
CANA.C is too cheap for a pot stock with the US based operations. .04 is major support. Watch for a breakout through .055 - .06 area.
Potential multi-bagger from current levels. Offering testing solutions for schools, airlines, arenas, stadiums, etc. Under $10M mkt cap with comparables trading at 5x to 10x.
BIOV.C may have found a bottom at ~ .19 after filling the gap with insiders recently buying at over .30. Approaching oversold area on the Daily chart.
Very bullish chart setup that is on the verge of breakout. EV space is hot and this company is one of the few under the radar gems that hasn't seen a run yet.
At $4.9M mkt cap with 17M float, I believe GSPR offers one of the best risk/reward in the junior mining space: - tight share structure with 25% held by insiders - 28% discount to just closed .40 financing ($500M) - high grade past producing Copper mine - adjacent to Teck Resources' Highland Valley Copper open pit operation - Copper prices are surging to multi-year...
MN.v is the *only* high grade Manganese project in North America that has a path to commercialization. Elon Musk recently said that the next gen EV batteries will be 1/3 Manganese. With many EV related stocks hitting fresh highs, the market is yet to notice this junior miner with a very unique project in Canada that has no competition in North America. Drilling...
BIOV is breaking out after a series of very promising press releases concerning their COVID-19 and cancer treatment/vaccine solutions. Still under the radar and will likely see lots of upside from here.
I am in at $2.35. - Oversold, RSI @ 21 - $9.5 USD financing just closed at $3.10 CDN with insiders/institutions buying ahead of COVID-19 treatment Phase 2 trial results - Will need to maintain $4+ stock price to stay listed on NASDAQ - Gaps above at 3.33 & 5.56 - Signs of bottoming out - $25M in cash; with Cannabis asset sale (~$20M), the cash position will exceed...
This one could easily multi-bag just by virtue of being too cheap at $1.5M market cap and super tight 10M float. Announced entering psychedelics space today but also has Health Canada license for PPE distribution. Multiple potential catalysts looming... Primo Nutraceuticals Inc., Engages MedCan Biotechnologies to Conduct Chemo typing & Geno-typing Studies of...
LABS presents a very good entry near .84 gap fill. Canaccord analyst has revised the price target to $2.50 after EU deal announcement and the company continues to produce excellent news flow. Strong support in the low .80s. Gap above at 1.69. Positive MACD divergence. Sector is finally turning bullish. I like this setup.
SSVRC has reported bonanza silver grades of 3,760 g/t over 2.5 m and is an absolute bargain at $60M mkt cap / 51M float compared to peers. The drilling program has been expanded to 12,500 m and we should be seeing more results reported soon. Strong management group with history of discoveries. Fully funded for 2020. Trading in historical support zone and getting...